OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
TERT promoter mutations in thyroid cancer
Rengyun Liu, Mingzhao Xing
Endocrine Related Cancer (2016) Vol. 23, Iss. 3, pp. R143-R155
Open Access | Times Cited: 365
Rengyun Liu, Mingzhao Xing
Endocrine Related Cancer (2016) Vol. 23, Iss. 3, pp. R143-R155
Open Access | Times Cited: 365
Showing 1-25 of 365 citing articles:
Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology
David L. Steward, Sally E. Carty, Rebecca S. Sippel, et al.
JAMA Oncology (2018) Vol. 5, Iss. 2, pp. 204-204
Open Access | Times Cited: 383
David L. Steward, Sally E. Carty, Rebecca S. Sippel, et al.
JAMA Oncology (2018) Vol. 5, Iss. 2, pp. 204-204
Open Access | Times Cited: 383
Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer
Rengyun Liu, Justin A. Bishop, Guangwu Zhu, et al.
JAMA Oncology (2016) Vol. 3, Iss. 2, pp. 202-202
Closed Access | Times Cited: 244
Rengyun Liu, Justin A. Bishop, Guangwu Zhu, et al.
JAMA Oncology (2016) Vol. 3, Iss. 2, pp. 202-202
Closed Access | Times Cited: 244
Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer
Ricardo Leão, Joana Apolónio, Dong‐Hyun Lee, et al.
Journal of Biomedical Science (2018) Vol. 25, Iss. 1
Open Access | Times Cited: 223
Ricardo Leão, Joana Apolónio, Dong‐Hyun Lee, et al.
Journal of Biomedical Science (2018) Vol. 25, Iss. 1
Open Access | Times Cited: 223
Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer
Seong‐Keun Yoo, Young Shin Song, Eun Kyung Lee, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 216
Seong‐Keun Yoo, Young Shin Song, Eun Kyung Lee, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 216
Novel targeted therapies and immunotherapy for advanced thyroid cancers
George E. Naoum, Michael Morkos, Brian W. Kim, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 207
George E. Naoum, Michael Morkos, Brian W. Kim, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 207
Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer
Rengyun Liu, Tao Zhang, Guangwu Zhu, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 163
Rengyun Liu, Tao Zhang, Guangwu Zhu, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 163
The regulations of telomerase reverse transcriptase (TERT) in cancer
Mingdi Liu, Yuning Zhang, Yong‐Ping Jian, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 28
Mingdi Liu, Yuning Zhang, Yong‐Ping Jian, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 28
Comprehensive screening for PD-L1 expression in thyroid cancer
Soomin Ahn, Tae Hyuk Kim, Sun Wook Kim, et al.
Endocrine Related Cancer (2017) Vol. 24, Iss. 2, pp. 97-106
Open Access | Times Cited: 143
Soomin Ahn, Tae Hyuk Kim, Sun Wook Kim, et al.
Endocrine Related Cancer (2017) Vol. 24, Iss. 2, pp. 97-106
Open Access | Times Cited: 143
Effects of CoexistentBRAFV600EandTERTPromoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis
Shinje Moon, Young Shin Song, Ye An Kim, et al.
Thyroid (2017) Vol. 27, Iss. 5, pp. 651-660
Closed Access | Times Cited: 140
Shinje Moon, Young Shin Song, Ye An Kim, et al.
Thyroid (2017) Vol. 27, Iss. 5, pp. 651-660
Closed Access | Times Cited: 140
Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma
Sarika Rao, Mark Zafereo, Ramona Dadu, et al.
Thyroid (2017) Vol. 27, Iss. 5, pp. 672-681
Open Access | Times Cited: 131
Sarika Rao, Mark Zafereo, Ramona Dadu, et al.
Thyroid (2017) Vol. 27, Iss. 5, pp. 672-681
Open Access | Times Cited: 131
Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance
Giorgia Acquaviva, Michela Visani, Andrea Repaci, et al.
Histopathology (2017) Vol. 72, Iss. 1, pp. 6-31
Open Access | Times Cited: 130
Giorgia Acquaviva, Michela Visani, Andrea Repaci, et al.
Histopathology (2017) Vol. 72, Iss. 1, pp. 6-31
Open Access | Times Cited: 130
TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease
Miguel Melo, Adriana Gaspar da Rocha, Rui Batısta, et al.
The Journal of Clinical Endocrinology & Metabolism (2017) Vol. 102, Iss. 6, pp. 1898-1907
Open Access | Times Cited: 125
Miguel Melo, Adriana Gaspar da Rocha, Rui Batısta, et al.
The Journal of Clinical Endocrinology & Metabolism (2017) Vol. 102, Iss. 6, pp. 1898-1907
Open Access | Times Cited: 125
Molecular targets of tyrosine kinase inhibitors in thyroid cancer
Poupak Fallahi, Silvia Martina Ferrari, Maria Rosaria Galdiero, et al.
Seminars in Cancer Biology (2020) Vol. 79, pp. 180-196
Closed Access | Times Cited: 113
Poupak Fallahi, Silvia Martina Ferrari, Maria Rosaria Galdiero, et al.
Seminars in Cancer Biology (2020) Vol. 79, pp. 180-196
Closed Access | Times Cited: 113
Sex differences in oncogenic mutational processes
Constance H. Li, Stephenie D. Prokopec, Ren Sun, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 108
Constance H. Li, Stephenie D. Prokopec, Ren Sun, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 108
Patient Age–Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer
Xiaopei Shen, Guangwu Zhu, Rengyun Liu, et al.
Journal of Clinical Oncology (2017) Vol. 36, Iss. 5, pp. 438-445
Open Access | Times Cited: 107
Xiaopei Shen, Guangwu Zhu, Rengyun Liu, et al.
Journal of Clinical Oncology (2017) Vol. 36, Iss. 5, pp. 438-445
Open Access | Times Cited: 107
The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer
Jiajun Liu, Rengyun Liu, Xiaopei Shen, et al.
Journal of Nuclear Medicine (2019) Vol. 61, Iss. 2, pp. 177-182
Open Access | Times Cited: 104
Jiajun Liu, Rengyun Liu, Xiaopei Shen, et al.
Journal of Nuclear Medicine (2019) Vol. 61, Iss. 2, pp. 177-182
Open Access | Times Cited: 104
Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
Jie-Rui Liu, Yanqing Liu, Yansong Lin, et al.
Endocrinology and Metabolism (2019) Vol. 34, Iss. 3, pp. 215-215
Open Access | Times Cited: 101
Jie-Rui Liu, Yanqing Liu, Yansong Lin, et al.
Endocrinology and Metabolism (2019) Vol. 34, Iss. 3, pp. 215-215
Open Access | Times Cited: 101
Molecular Alterations in Thyroid Carcinoma
Mohamed Rizwan Haroon Al Rasheed, Bin Xu
Surgical pathology clinics (2019) Vol. 12, Iss. 4, pp. 921-930
Open Access | Times Cited: 101
Mohamed Rizwan Haroon Al Rasheed, Bin Xu
Surgical pathology clinics (2019) Vol. 12, Iss. 4, pp. 921-930
Open Access | Times Cited: 101
Telomeres and telomerase in oncogenesis (Review)
Tomasz Trybek, Artur Kowalik, Stanisław Góźdż, et al.
Oncology Letters (2020) Vol. 20, Iss. 2, pp. 1015-1027
Open Access | Times Cited: 95
Tomasz Trybek, Artur Kowalik, Stanisław Góźdż, et al.
Oncology Letters (2020) Vol. 20, Iss. 2, pp. 1015-1027
Open Access | Times Cited: 95
Multiplatform molecular test performance in indeterminate thyroid nodules
Mark A. Lupo, Ann E. Walts, J. Woody Sistrunk, et al.
Diagnostic Cytopathology (2020) Vol. 48, Iss. 12, pp. 1254-1264
Open Access | Times Cited: 92
Mark A. Lupo, Ann E. Walts, J. Woody Sistrunk, et al.
Diagnostic Cytopathology (2020) Vol. 48, Iss. 12, pp. 1254-1264
Open Access | Times Cited: 92
Clinical utility of RAS mutations in thyroid cancer: a blurred picture now emerging clearer
Mingzhao Xing
BMC Medicine (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 90
Mingzhao Xing
BMC Medicine (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 90
The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition
Gilda Varricchi, Stefania Loffredo, Giancarlo Marone, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 16, pp. 3934-3934
Open Access | Times Cited: 90
Gilda Varricchi, Stefania Loffredo, Giancarlo Marone, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 16, pp. 3934-3934
Open Access | Times Cited: 90
Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS
Ji Min Oh, Byeong‐Cheol Ahn
Theranostics (2021) Vol. 11, Iss. 13, pp. 6251-6277
Open Access | Times Cited: 90
Ji Min Oh, Byeong‐Cheol Ahn
Theranostics (2021) Vol. 11, Iss. 13, pp. 6251-6277
Open Access | Times Cited: 90
Molecular Pathology of Anaplastic Thyroid Carcinomas: A Retrospective Study of 144 Cases
Benjamin Bonhomme, Yann Godbert, Gaëlle Pérot, et al.
Thyroid (2017) Vol. 27, Iss. 5, pp. 682-692
Closed Access | Times Cited: 89
Benjamin Bonhomme, Yann Godbert, Gaëlle Pérot, et al.
Thyroid (2017) Vol. 27, Iss. 5, pp. 682-692
Closed Access | Times Cited: 89
Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation
Naoki Oishi, Tetsuo Kondo, Aya Ebina, et al.
Modern Pathology (2017) Vol. 30, Iss. 11, pp. 1527-1537
Open Access | Times Cited: 89
Naoki Oishi, Tetsuo Kondo, Aya Ebina, et al.
Modern Pathology (2017) Vol. 30, Iss. 11, pp. 1527-1537
Open Access | Times Cited: 89
